Real-World Evidence Under Consideration For Use In Interchangeable Biosimilar Applications

Planned Research And Guidances Included As Part Of BSUFA III

 
• By Derrick Gingery
  
Questions to be answered
Labeling, promotional and other draft interchangeability guidances are required to be issued during BsUFA III • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products